ProfileGDS4459 / ENSG00000198453
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 45% 29% 44% 37% 41% 49% 41% 41% 41% 39% 45% 51% 40% 44% 31% 35% 49% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.2445
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.7429
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 34.1444
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.0737
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.0541
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.3749
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.0741
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 84.0141
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 94.0141
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 103.9839
GSM623474group B, liver allograft wedge biopsie placebo treatment 14.145
GSM623475group B, liver allograft wedge biopsie placebo treatment 24.4251
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.0440
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.2244
GSM623478group B, liver allograft wedge biopsie placebo treatment 53.5531
GSM623479group B, liver allograft wedge biopsie placebo treatment 63.9135
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.3649